Trends in lipid profiles in patients with psoriasis: a population-based analysis

Bharath M. Akkara Veetil, Eric Lawrence Matteson, Hilal D Maradit Kremers, Marian T. McEvoy, Cynthia Crowson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Psoriasis is associated with an atherogenic lipid profile but longitudinal changes in lipids around disease onset are unknown. The purpose of our study is to examine the effect of psoriasis onset on serum lipid profiles.Methods: We compared changes in lipid profiles in a population based incident cohort of 689 patients with psoriasis and 717 non-psoriasis subjects. All lipid measures performed 5 years before and after psoriasis incidence/index date were abstracted. Random-effects models adjusting for age, sex and calendar year were used to examine trends in lipid profiles.Results: There were significant declines in total cholesterol (TC) and low-density lipoprotein (LDL) levels during the 5 years before and after psoriasis incidence/index date in both the psoriasis and the non-psoriasis cohorts, with a greater decrease noted in the TC levels (p=0.022) and LDL (p=0.054) in the non-psoriasis cohort. High-density lipoprotein (HDL) levels increased significantly both before and after psoriasis incidence date in the psoriasis cohort. Triglyceride (TG) levels were significantly higher (p<0.001), and HDL levels significantly lower (p=0.013) in patients with psoriasis compared to non-psoriasis subjects. There were no differences in prescriptions for lipid lowering drugs between the two cohorts.Conclusions: Patients with psoriasis had a significant decrease in TC and LDL levels during the 5 years before psoriasis incidence. Higher mean TG and lower mean HDL levels were noted in the 5 years before psoriasis incidence. These changes are unlikely to be caused by lipid lowering treatment alone and require further exploration.

Original languageEnglish (US)
Article number20
JournalBMC Dermatology
Volume12
DOIs
StatePublished - Oct 30 2012

Fingerprint

Psoriasis
Lipids
Population
HDL Lipoproteins
Incidence
LDL Cholesterol
Triglycerides
LDL Lipoproteins
Prescriptions
Cholesterol

Keywords

  • Epidemiology
  • Lipids
  • Psoriasis

ASJC Scopus subject areas

  • Dermatology

Cite this

Trends in lipid profiles in patients with psoriasis : a population-based analysis. / Akkara Veetil, Bharath M.; Matteson, Eric Lawrence; Maradit Kremers, Hilal D; McEvoy, Marian T.; Crowson, Cynthia.

In: BMC Dermatology, Vol. 12, 20, 30.10.2012.

Research output: Contribution to journalArticle

@article{bbe4fb0684f442f194e51677588699fe,
title = "Trends in lipid profiles in patients with psoriasis: a population-based analysis",
abstract = "Background: Psoriasis is associated with an atherogenic lipid profile but longitudinal changes in lipids around disease onset are unknown. The purpose of our study is to examine the effect of psoriasis onset on serum lipid profiles.Methods: We compared changes in lipid profiles in a population based incident cohort of 689 patients with psoriasis and 717 non-psoriasis subjects. All lipid measures performed 5 years before and after psoriasis incidence/index date were abstracted. Random-effects models adjusting for age, sex and calendar year were used to examine trends in lipid profiles.Results: There were significant declines in total cholesterol (TC) and low-density lipoprotein (LDL) levels during the 5 years before and after psoriasis incidence/index date in both the psoriasis and the non-psoriasis cohorts, with a greater decrease noted in the TC levels (p=0.022) and LDL (p=0.054) in the non-psoriasis cohort. High-density lipoprotein (HDL) levels increased significantly both before and after psoriasis incidence date in the psoriasis cohort. Triglyceride (TG) levels were significantly higher (p<0.001), and HDL levels significantly lower (p=0.013) in patients with psoriasis compared to non-psoriasis subjects. There were no differences in prescriptions for lipid lowering drugs between the two cohorts.Conclusions: Patients with psoriasis had a significant decrease in TC and LDL levels during the 5 years before psoriasis incidence. Higher mean TG and lower mean HDL levels were noted in the 5 years before psoriasis incidence. These changes are unlikely to be caused by lipid lowering treatment alone and require further exploration.",
keywords = "Epidemiology, Lipids, Psoriasis",
author = "{Akkara Veetil}, {Bharath M.} and Matteson, {Eric Lawrence} and {Maradit Kremers}, {Hilal D} and McEvoy, {Marian T.} and Cynthia Crowson",
year = "2012",
month = "10",
day = "30",
doi = "10.1186/1471-5945-12-20",
language = "English (US)",
volume = "12",
journal = "BMC Dermatology",
issn = "1471-5945",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Trends in lipid profiles in patients with psoriasis

T2 - a population-based analysis

AU - Akkara Veetil, Bharath M.

AU - Matteson, Eric Lawrence

AU - Maradit Kremers, Hilal D

AU - McEvoy, Marian T.

AU - Crowson, Cynthia

PY - 2012/10/30

Y1 - 2012/10/30

N2 - Background: Psoriasis is associated with an atherogenic lipid profile but longitudinal changes in lipids around disease onset are unknown. The purpose of our study is to examine the effect of psoriasis onset on serum lipid profiles.Methods: We compared changes in lipid profiles in a population based incident cohort of 689 patients with psoriasis and 717 non-psoriasis subjects. All lipid measures performed 5 years before and after psoriasis incidence/index date were abstracted. Random-effects models adjusting for age, sex and calendar year were used to examine trends in lipid profiles.Results: There were significant declines in total cholesterol (TC) and low-density lipoprotein (LDL) levels during the 5 years before and after psoriasis incidence/index date in both the psoriasis and the non-psoriasis cohorts, with a greater decrease noted in the TC levels (p=0.022) and LDL (p=0.054) in the non-psoriasis cohort. High-density lipoprotein (HDL) levels increased significantly both before and after psoriasis incidence date in the psoriasis cohort. Triglyceride (TG) levels were significantly higher (p<0.001), and HDL levels significantly lower (p=0.013) in patients with psoriasis compared to non-psoriasis subjects. There were no differences in prescriptions for lipid lowering drugs between the two cohorts.Conclusions: Patients with psoriasis had a significant decrease in TC and LDL levels during the 5 years before psoriasis incidence. Higher mean TG and lower mean HDL levels were noted in the 5 years before psoriasis incidence. These changes are unlikely to be caused by lipid lowering treatment alone and require further exploration.

AB - Background: Psoriasis is associated with an atherogenic lipid profile but longitudinal changes in lipids around disease onset are unknown. The purpose of our study is to examine the effect of psoriasis onset on serum lipid profiles.Methods: We compared changes in lipid profiles in a population based incident cohort of 689 patients with psoriasis and 717 non-psoriasis subjects. All lipid measures performed 5 years before and after psoriasis incidence/index date were abstracted. Random-effects models adjusting for age, sex and calendar year were used to examine trends in lipid profiles.Results: There were significant declines in total cholesterol (TC) and low-density lipoprotein (LDL) levels during the 5 years before and after psoriasis incidence/index date in both the psoriasis and the non-psoriasis cohorts, with a greater decrease noted in the TC levels (p=0.022) and LDL (p=0.054) in the non-psoriasis cohort. High-density lipoprotein (HDL) levels increased significantly both before and after psoriasis incidence date in the psoriasis cohort. Triglyceride (TG) levels were significantly higher (p<0.001), and HDL levels significantly lower (p=0.013) in patients with psoriasis compared to non-psoriasis subjects. There were no differences in prescriptions for lipid lowering drugs between the two cohorts.Conclusions: Patients with psoriasis had a significant decrease in TC and LDL levels during the 5 years before psoriasis incidence. Higher mean TG and lower mean HDL levels were noted in the 5 years before psoriasis incidence. These changes are unlikely to be caused by lipid lowering treatment alone and require further exploration.

KW - Epidemiology

KW - Lipids

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=84867898134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867898134&partnerID=8YFLogxK

U2 - 10.1186/1471-5945-12-20

DO - 10.1186/1471-5945-12-20

M3 - Article

C2 - 23110323

AN - SCOPUS:84867898134

VL - 12

JO - BMC Dermatology

JF - BMC Dermatology

SN - 1471-5945

M1 - 20

ER -